Pellets Pharma Limited, a active public limited company, was established on 11 March 2004 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2004PLC042853. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹8.34 M.
It upholds a compliant status. Employing 177 professional, Its leadership includes Srinivasa Rao Jetti (Whole-Time Director), Pathuru Sreelatha (Managing Director), Pathuru Vamsi Krishna (Whole-Time Director). Past directors included Gaddipati Sankar Basava, Mohan Gaddipati Rao, Pathuru Sreelatha. It holds no open charges and ₹2.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.784, Vivekananda Nagar Colony Kukatpally, Hyderabad, Telangana, 500072.
U24239TG2004PLC042853
042853
11 March 2004
₹1.50 Cr
₹8.34 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Pellets Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasa Rao Jetti | Whole-Time Director | 30 Sep 2024 | Current |
| Pathuru Sreelatha | Managing Director | 11 Mar 2004 | Current |
| Pathuru Vamsi Krishna | Whole-Time Director | 18 Jul 2019 | Current |
| Pathuru Aasritha | Director | 30 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Mar 2009 | Past |
| Pramod Abcsdd | Director | 11 Mar 2009 | Past |
| Pramod Abcsdd | Whole-Time Director | 08 Jan 2019 | Past |
| Pramod Abcsdd | Managing Director | 02 Mar 2019 | Past |
| Pramod Abcsdd | Director | 11 Mar 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pellets Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.6% increase. The company also saw a substantial improvement in profitability, with a 318.01% increase in profit. The company's net worth moved up by a moderate rise of 8.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Pellets Pharma had a promoter holding of 96.96% and a public holding of 3.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2005 | The Dhanalakshmi Bank Ltd | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Pellets Pharma has a workforce of 177 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pellets Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pellets Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pellets Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Srinivasa Rao Jetti was appointed as a Whole-time director was appointed as a Whole-time director on 30 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
The activity Pathuru Aasritha was appointed as a Director was appointed as a Director on 30 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
Pellets Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Pathuru Vamsi Krishna was appointed as a Whole-time director was appointed as a Whole-time director on 18 Jul 2019 & has been associated with this company since 6 years 4 months . was completed.
A charge registered on 29 Mar 2005 via Charge ID 90127008 with The Dhanalakshmi Bank Ltd was fully satisfied on 21 Mar 2017. was recorded as a recent event.
The CIN of Pellets Pharma Limited is U24239TG2004PLC042853.
Pellets Pharma Limited is headquartered at Plot No.784, Vivekananda Nagar Colony Kukatpally, Hyderabad, Telangana, 500072.
Pellets Pharma Limited was incorporated on 11 March 2004.
The current directors of Pellets Pharma Limited are
The primary industry of Pellets Pharma Limited is Manufacturing.
Pellets Pharma Limited is unlisted.
The authorized capital of Pellets Pharma Limited is ₹1.50 Cr, and the paid-up capital is ₹8.34 M.
The compliance status of Pellets Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX